Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

BioCryst Pharmaceuticals Inc BCRX

Sector: Healthcare | Sub-Sector: Biotechnology

Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.
Price: $11.71 | Change: +$0.44 | %Change: +3.90%
Volume: 409,930 | Day High/Low: 11.75/11.21 | 52 Week High/Low: 13.33/2.83

Snapshot

Last Traded: July 22, 2014 10:50 Transaction Volume: 409,930
Open: $11.71 Previous Close: $11.27
Bid: $11.70 Ask: $11.72
Bid Size: 16 Ask Size: 100
Market Cap: $838.1m Shares Out: 71.6m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts